Reply to Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it?

Kiran Naqvi, Hagop M. Kantarjian

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)4261
Number of pages1
JournalCancer
Volume124
Issue number21
DOIs
StatePublished - Nov 1 2018

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this